Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.: how funds voted at the meeting of 29 Feb 2024
- Meeting
- Season
- year to 30 June 2024
- Filers reporting
- 38
- Ballot items
- 3
38 filers on Form N-PX reported votes at the Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. meeting of 29 Feb 2024. The records fall into 3 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.
This meeting is in the year to 30 June 2024. The latest season on file is the year to 30 June 2026. The page of Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. has the latest meeting.
If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.
The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .
The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.
The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.
The page gives records. It gives no investment advice and no advice on how to vote.
Season on this page: year to 30 June 2024. Filings read through . How the figures are made
The ballot
Item 1: Audit-related items (auditor ratification)
9 vote records from 6 filers. 1 of the 6 filers that marked the item voted against management.
- Positions of 3 fund families
- For 3
Item 2: COMPENSATION: management items
The company's items in this category are shown together, because filers word and number them differently.
63 vote records from 30 filers. 0 of the 30 filers that marked the item voted against management.
- Positions of 15 fund families
- For 15
Item 3: CORPORATE GOVERNANCE: management items
The company's items in this category are shown together, because filers word and number them differently.
74 vote records from 37 filers. 34 of the 37 filers that marked the item voted against management.
- Positions of 19 fund families
- For 1
- Against 18
- Against management 18
Positions of the fund families
A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.
KeyForAgainstAbstain or withholdSplit or no voteAgainst management
| Fund family | 1. Auditor |
|---|---|
| J.P. Morgan | For |
| Jackson National funds | For |
| John Hancock and Manulife | For |
Questions
- How many filers reported votes at the Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. meeting?
- 38 Form N-PX filers reported votes at the meeting of 29 Feb 2024.
- Is this the result of the meeting?
- No. The page counts the filers that report on Form N-PX, and the shares they reported. Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. reports the result of a vote on Form 8-K.
- Why does the page show counts only for director elections?
- A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. with a meeting date within three days of 29 Feb 2024. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .